Catalent reports upbeat Q4 results as it awaits FTC review of $16.5B sale to Novo 0 30.08.2024 15:31 Fiercepharma.com Catalent reports upbeat Q4 results as it awaits FTC review of $16.5B sale to Novo jkeenan Fri, 08/30/2024 - 08:31
